MediWound Ltd is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel products to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and others.
$5.12
As of 02/26/2021 IEX book CBOE book
2021 © Stock Market MBA, Inc.